Skip to main content
Premium Trial:

Request an Annual Quote

Motorola Launches First Bioarray; More Set to Follow Through January

NEW YORK, Aug. 15 – Motorola Life Sciences introduced its high-density human genome bioarray on Wednesday as part of its CodeLink bioarray systems launch.

The introduction, made at the Drug Discovery Technology 2001 conference in Boston, launches Motorola’s Uniset Human I bioarray, which the company said includes approximately 9,200 unique oligonucleotides representing human EST clusters. 

The bioarray content comes from sequences in the public UniGene database that was compared and confirmed against Incyte’s LifeSeq database, Scott Magnuson, Motorola Life Sciences’ head of genomics and bioinformatics, told GenomeWeb .

The launch marks the first in a series of bioarrays that Motorola has scheduled to unveil over the next five months, according to Mike James, vice president of commercial operations at Motorola Life Sciences. 

These products include a 10K rat genome bioarray, which is slated to appear in September; a Uniset II human array that features additional UniGene data plus data from Incyte, scheduled to be introduced around the end of the year; and an array designed to measure SNPs within the P450 gene family, which will launch at year’s end.

All of the bioarrays are designed around Motorola’s new CodeLink software and database platform. 

The Uniset Human I bioarray is targeted at researchers already using pre-fabricated arrays in addition to researchers who self-spot, said Bill Coty, Motorola Life Sciences’ director of product development.  

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.